What Happened?
, -based Sensei Biotherapeutics Promoted Chris Gerry as SVP, General Counsel and Corporate Secretary
About the Company
Driven by world class scientists and an entrepreneurial culture focused on rigorous science, innovative treatments, and data-driven decision making, we discover and develop medicines that have the potential to alter the treatment landscape and contribute value to patients and society. The company has developed a unique drug discovery approach, ImmunoPhage™️, that generates powerful and specific immune responses. Its most advanced program, SNS-301, is currently enrolling patients in Phase 1/2 clinical trials.
About the Person
Chris Gerry is SVP, General Counsel and Corporate Secretary at Sensei Biotherapeutics. Previously, Chris held various senior legal leadership roles in the industry.
Info Source
News
Short Profile